Trial intelligence / Profile preview

Chlorhexidine for preventing diabetic foot ulcers

NCT03503370Phase 2Completed

Sponsor
VA Office of Research & Development
Start
Jan 2019
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of chlorhexidine in diabetic foot ulcer (DFU), sponsored by VA Office of Research & Development. Started Jan 2019; status: completed.

02

Drugs

chlorhexidine
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT03503370.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03503370.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call